Abstracts to be considered for in-person presentations:

Challenging case: These should include educational elements such as the problem or difficulty, how to avoid and resolve it.
Free paper: These should correspond to complete studies with outstanding results and innovative conclusions.

You can select within the following topics:

– Challenging cases/Free papers in PAD therapy

– Challenging cases/Free papers in Aorta and its branches

– Challenging cases LECO* – Aorta and its branches

– Challenging cases LECO* – PAD therapy

– Challenging cases/Free papers in Vascular Nursing

(* To learn more about LECO – Learning from Endovascular Complications for Better Outcome please click here)

When submitting your abstract, you should select your preference.

The 3 best abstracts for each topic will be chosen for presentation.

The best Oral presentation will be awarded with the prize of 2,500€.

The best poster will be awarded with the prize of 1,500€.

All abstracts must be submitted through the official link posted at the end of this page.

The deadline to submit your abstract is 31^st  August 2026.

An acceptance/rejection notification will be sent via email with all the necessary presentation details by 8^th September 2026.

The maximum number of authors permitted is 6 (1 author plus 5 co-authors). One of the authors must be registered in the Symposium.

The title should be in capitals and extend to no more than two lines. Avoid abbreviations.

Organize the text following these sections:

– Introduction

– Objectives

– Material used

– Methodology used

– Results of the study

– Conclusions of the study

We are pleased to announce the 4^th Edition of these awards for Medical Vascular Startups.
Open to cutting-edge medical technology startups from across the globe.
The 3 best projects will be elected to pitch their startup company in a plenary session of the SITE Santiago 2026.
Deadline for applications is 31^st  August 2026.

An acceptance/rejection notification will be sent via email with all the necessary presentation details by 8^th September 2026.

This award can help med-tech startup:

– Gain invaluable international investment community and key industry players

– Reach the next level in the pathway to clinical approval and adoption

– Obtain invaluable guidance and endorsement from world-class panel and peers

The competition is open to pre-seed and seed-stage med tech startup companies whose innovative solutions can be applied to vascular diagnostics and interventions. We will consider the following areas:

– Medical Devices

– Digital/Mobile Health / Health ICT

– Biomedicine

– Medical Consumer Products

– Medical Diagnostics

– Medical Therapeutics

– Healthcare Services/Processes

Participation is very easy:

– Insert your pitch

– Your idea will be reviewed by the committee and a notification will be soon sent regarding your compatibility to the SITE Innovation award.

– Once confirmed by the committee you will be invited to the extended submission stage. You will then be required to send a partial business plan (instructions will be provided) for the review of committee.

– The committee will select three proposals be presented in a live session during the SITE Santiago 2026.

– The best presentation will receive a 2.000€ prize award.

SUBMISSION RULES

• The abstract should be as informative and succinct as possible.
• Organize the text following these sections:
  • Project name
  • Name of the organization/startup
  • Website (if available)
  • Unmet need
  • Proposed solution
  • Project status (select the stage most adjusted to the maturity of your project)
    • Need: Insights into unmet clinical needs and available solutions
    • Idea: Potential solutions to the unmet need developed and evaluated
    • Proof of concept: Key component concepts validated in models and value proposition articulated
    • Proof of feasibility: Feasibility of solution demonstrated, with tests and with feedback of stakeholders
    • Proof of value: Demonstration that the solution works (trials in animals) and creates value for stakeholders
    • Clinical trials: Manufacture of pilot lots and collection of first results of clinical trials
    • Other: Project status higher than 6
  • Status of the invention (please check if any of the following options apply. You can either select none, one or more than one option(s)):
    • Patent application submitted
    • Invention disclosed publicly (published in journal, presented at conference or other submission)
    • Product commercially released
    • Product received regulatory approval
    • Intellectual property licensed to third party
  • State of the art and competition (provide a list of existing and/or potential alternatives, the description of how others have addressed the problem and the advantages of your invention over them).
  • Market volume (if known, provide data of the market -units, €- and/or prevalence of the disease.
  • Additional information (if necessary, please provide any additional non-confidential information that could be of interest for the evaluation of your Project such as Road map, business plan, financing required…

You must understand that the information disclosed herein is NON-CONFIDENTIAL. In case that you want to share any confidential information, in order to provide a better explication of the product/service, please contact us at: sitesecretariat@doctaforum.com.

To go back to the symposium website click here.

The Vascular Nursing programme of SITE Santiago 2026 will accept abstracts in English and Spanish (both for submission and onsite presentations)

To see abstract submission rules in Spanish click here.

There are 3 types of presentations that can be submitted to the congress:

Oral Presentations:

• Description: Presentations where authors present their research, projects, or clinical experiences in detail.
• Duration: Each presentation lasts 8 minutes, followed by a Q&A session after all presentations.
• Objective: To facilitate the exchange of knowledge and foster debate among attendees.

Defended Posters:

• Description: Visual works summarizing research or projects. Posters will be displayed in designated areas throughout the congress.
• Presentation: Each presentation lasts 5 minutes. After all poster presentations, there will be a Q&A and debate session.
• Objective: To provide a quick and concise overview of the works, allowing direct interaction with the authors.

Nursing Clinical Cases:

• Description: Detailed presentations of relevant clinical cases highlighting nursing interventions, challenges, and outcomes.
• Format: These will be presented orally, with a duration of 6 minutes.
• Objective: To share practical experiences and lessons learned that can be applied in similar situations.

Abstract Format and Length for All Presentations:

• Title: Should be brief and related to the content of the work. No abbreviations or acronyms should be included.
• Length: The abstract should not exceed 2400 characters, including spaces.
• Tables and Images: Tables should have a maximum of 12 columns by 20 rows. Images should have a minimum resolution of 300×200 pixels and a maximum of 900×600 pixels.
• General Guidelines:
  • Do not include abbreviations or bibliographic references.
  • Do not include the names of authors, workplaces, cities, or commercial brands in the abstract.
  • Authors must select the appropriate category for their abstract when submitting it.
  • Author Preferences: When submitting the abstract, authors can indicate their preference for the presentation format (oral communication or poster). The Scientific Committee will consider these preferences, but the final decision on the presentation format will be determined by the Committee based on the quality and relevance of the work.
  • Accepted abstracts will be notified to the authors along with instructions for the presentation format (oral, poster, etc.).

Abstract Content:

• Introduction: Should focus on the field of study of the vascular patient and describe the objective of the work in the last paragraph.
• Materials and Methods: Indicate the type of study design developed, sample selection, data collection instruments, and data analysis.
• Results: Should be clear and concise, specifying the most relevant results of the study.
• Conclusions: Summarize the implications of the results and their relevance to clinical practice.

Abstract Content for Nursing Clinical Case Presentations:

• Introduction: Brief description of the context and relevance of the clinical case, and describe the objective of the work in the last paragraph.
• Case Description: Details of the patient, including demographic data, relevant medical history, and clinical presentation.
• Nursing Interventions: Description of the interventions performed, including the care provided and strategies implemented.
• Results: Results obtained from the nursing interventions, including patient evolution and any significant changes in their condition.
• Discussion: Analysis of the results, highlighting the lessons learned and the relevance of the case to nursing practice.
• Conclusions: Summary of key points and their impact on clinical practice.

Evaluation and Submission: All abstracts will be evaluated by the Scientific Committee of the nursing congress without identifying the authors or their affiliations.

Registration: It is essential that the person who will present the work completes their registration for the congress.